{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:59:07Z","timestamp":1790848747381,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007195","name":"University of Naples Federico II","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omton.2026.201320","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:16:50Z","timestamp":1786519010000},"page":"201320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Additive effect of Ruta graveolens bioactive phytoconstituents and cisplatin through PKC\/MEK\/ERK pathway in glioblastoma"],"prefix":"10.1016","volume":"34","author":[{"given":"Grazia","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Morgera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pezone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Iovinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ciniglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Porcellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0436-4621","authenticated-orcid":false,"given":"Antonia","family":"Feola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201320_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.omton.2026.201320_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trecan.2022.09.005","article-title":"Challenges in glioblastoma research: focus on the tumor microenvironment","volume":"9","author":"Bikfalvi","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.omton.2026.201320_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood\u2013brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.omton.2026.201320_bib4","article-title":"An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma","volume":"10","author":"Yang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omton.2026.201320_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1158\/0008-5472.CAN-22-1890","article-title":"Stromal Reprogramming through Dual PDGFR\u03b1\/\u03b2 Blockade Boosts the Efficacy of Anti\u2013PD-1 Immunotherapy in Fibrotic Tumors","volume":"83","author":"Akiyama","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201320_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yexcr.2018.01.025","article-title":"Ruta graveolens water extract inhibits cell-cell network formation in human umbilical endothelial cells via MEK-ERK1\/2 pathway","volume":"364","author":"Gentile","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omton.2026.201320_bib7","first-page":"1","article-title":"Trametinib Combined with Pazopanib for Treating Malignant Peripheral Nerve Sheath Tumor in NF-1 Patients: A Case Report and a Review of the Literature","volume":"10","author":"Feola","year":"2025","journal-title":"Annals of Case Reports"},{"key":"10.1016\/j.omton.2026.201320_bib8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3892\/mco.2013.172","article-title":"Glioma and glioblastoma \u2013 how much do we (not) know?","volume":"1","author":"Jov\u010devska","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201320_bib9","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/cancers13102317","article-title":"Natural Compounds in Glioblastoma Therapy: Preclinical Insights, Mechanistic Pathways, and Outlook","volume":"13","author":"Zhai","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2026.201320_bib10","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/brainsci13111536","article-title":"Advances in Glioblastoma Therapy: An Update on Current Approaches","volume":"13","author":"Angom","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.omton.2026.201320_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2024.100534","article-title":"Assessment of Antioxidant Potential, Cytotoxicity, and Anticancer Activity of Methanolic Extracts from Selected Wild Medicinal Plants","volume":"4","author":"Al Qaisi","year":"2024","journal-title":"Phytomed. Plus"},{"key":"10.1016\/j.omton.2026.201320_bib12","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.2147\/DDDT.S494417","article-title":"Traditional Uses, Phytochemistry, Pharmacology and Toxicology of Ruta graveolens L.: A Critical Review and Future Perspectives","volume":"18","author":"Luo","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.omton.2026.201320_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118864","article-title":"Ruta graveolens L. Induces Death of Glioblastoma Cells and Neural Progenitors, but Not of Neurons, via ERK1\/2 and AKT Activation","volume":"10","author":"Gentile","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.omton.2026.201320_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.biochi.2006.09.006","article-title":"Role of quercetin and its in vivo metabolites in protecting H9c2 cells against oxidative stress","volume":"89","author":"Angeloni","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.omton.2026.201320_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1057943","article-title":"Isorhamnetin Induces Melanoma Cell Apoptosis via the PI3K\/Akt and NF-\u03baB Pathways","volume":"2020","author":"Duan","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.omton.2026.201320_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.canlet.2008.05.040","article-title":"Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis","volume":"270","author":"Lee","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2026.201320_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9913179","article-title":"Rutin: A Flavonoid as an Effective Sensitizer for Anticancer Therapy; Insights into Multifaceted Mechanisms and Applicability for Combination Therapy","volume":"2021","author":"Satari","year":"2021","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.omton.2026.201320_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305547","article-title":"Dampened Regulatory Circuitry of TEAD1\/ITGA1\/ITGA2 Promotes TGF\u03b21 Signaling to Orchestrate Prostate Cancer Progression","volume":"11","author":"Cruz","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omton.2026.201320_bib19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cels.2017.03.004","article-title":"A Cell-Surface Membrane Protein Signature for Glioblastoma","volume":"4","author":"Ghosh","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.omton.2026.201320_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-11758-6","article-title":"KRAS is a molecular determinant of platinum responsiveness in glioblastoma","volume":"24","author":"Zuchegna","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omton.2026.201320_bib21","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1091\/mbc.e06-10-0908","article-title":"ERK Activity and G1 Phase Progression: Identifying Dispensable Versus Essential Activities and Primary Versus Secondary Targets","volume":"18","author":"Villanueva","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.omton.2026.201320_bib22","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.bbamem.2007.05.027","article-title":"Modification of membranes by quercetin, a naturally occurring flavonoid, via its incorporation in the polar head group","volume":"1768","author":"Pawlikowska-Pawl\u0119ga","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omton.2026.201320_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111489","article-title":"Flavonoids and Their Role in Oxidative stress, inflammation, and Human Diseases","volume":"413","author":"Jomova","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.omton.2026.201320_bib24","first-page":"1","article-title":"Flavonoids: A versatile source of anticancer drugs","volume":"5","author":"Chahar","year":"2011","journal-title":"Pharmacogn. Rev."},{"key":"10.1016\/j.omton.2026.201320_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2023.100167","article-title":"Flavonoids as promising molecules in the cancer therapy: An insight","volume":"6","author":"Mir","year":"2024","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"10.1016\/j.omton.2026.201320_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2021.105160","article-title":"Quercetin induces lipid domain-dependent permeability","volume":"242","author":"Leite","year":"2022","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.omton.2026.201320_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omton.2026.201320_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-21272-3","article-title":"Modulation of the blood\u2013brain barrier permeability by patient-derived glioblastoma stem cell secretome","volume":"15","author":"Sica","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201320_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/914273","article-title":"Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects","volume":"2012","author":"Vauzour","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.omton.2026.201320_bib30","first-page":"233","article-title":"Ruta graveolens extract induces DNA damage pathways and blocks Akt activation to inhibit cancer cell proliferation and survival","volume":"31","author":"Fadlalla","year":"2011","journal-title":"Anticancer research"},{"key":"10.1016\/j.omton.2026.201320_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(19)84046-2","article-title":"Ca2+- and Protein Kinase C-dependent Signaling Pathway for Nuclear Factor-\u03baB Activation, Inducible Nitric-oxide Synthase Expression, and Tumor Necrosis Factor-\u03b1 Production in Lipopolysaccharide-stimulated Rat Peritoneal Macrophages","volume":"281","author":"Zhou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201320_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1641752","article-title":"Chemotherapeutic nanoparticles for glioblastoma","volume":"15","author":"Messina","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2026.201320_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbrc.2004.06.003","article-title":"Ras inhibition amplifies cisplatin sensitivity of human glioblastoma","volume":"320","author":"Messina","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omton.2026.201320_bib34","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2174\/0118715303320523240910072723","article-title":"Anticancer Potential of Quercetin, Epigallocatechin Gallate, Kaempferol, Apigenin, and Curcumin against Several Human Carcinomas","volume":"25","author":"Singh","year":"2025","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.omton.2026.201320_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2176\/nmc.28.965","article-title":"In Vitro Effects of ACNU, BCNU, CDDP, and Bleomycin on Human Glioma Cells","volume":"28","author":"Iwata","year":"1988","journal-title":"Neurol. Med. Chir."},{"key":"10.1016\/j.omton.2026.201320_bib36","first-page":"992","article-title":"Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture","volume":"42","author":"Yung","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201320_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00432-022-04483-3","article-title":"Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo","volume":"149","author":"Houweling","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201320_bib38","article-title":"Combination MEK and mTOR inhibitor therapy is active in models of glioblastoma","volume":"2","author":"Schreck","year":"2020","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.omton.2026.201320_bib39","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omton.2026.201320_bib40","article-title":"Neoadjuvant combination treatment with checkpoint inhibitors, chemotherapy, and BRAF\/MEK inhibitors for BRAFV600E glioblastoma results in sustained response: A case report","volume":"6","author":"Wagle","year":"2024","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.omton.2026.201320_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6874146","article-title":"H9c2 Cardiomyocytes under Hypoxic Stress: Biological Effects Mediated by Sentinel Downstream Targets","volume":"2021","author":"Boccellino","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.omton.2026.201320_bib42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omton.2026.201320_bib43","first-page":"2788","article-title":"The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF\/Mdm2 but not p53 alterations in fresh human gliomas","volume":"7","author":"Calogero","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201320_bib44","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/jcp.25592","article-title":"Overexpression of Large-Conductance Calcium-Activated Potassium Channels in Human Glioblastoma Stem-Like Cells and Their Role in Cell Migration","volume":"232","author":"Rosa","year":"2017","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.omton.2026.201320_bib45","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.3390\/ijms23179563","article-title":"Polysialic Acid Sustains the Hypoxia-Induced Migration and Undifferentiated State of Human Glioblastoma Cells","volume":"23","author":"Rosa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2026.201320_bib46","article-title":"Polysialylation of Glioblastoma Cells Is Regulated by Autophagy Under Nutrient Deprivation","volume":"26","author":"Scibetta","year":"2025","journal-title":"Int. J. Mol."},{"key":"10.1016\/j.omton.2026.201320_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1090197","article-title":"Genomic study and lipidomic bioassay of Leeuwenhoekiella parthenopeia: A novel rare biosphere marine bacterium that inhibits tumor cell viability","volume":"13","author":"Gattoni","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omton.2026.201320_bib48","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/jcb.24558","article-title":"The inhibition of p85\u03b1PI3KSer83 phosphorylation prevents cell proliferation and invasion in prostate cancer cells","volume":"114","author":"Feola","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.omton.2026.201320_bib49","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(94)90133-3","article-title":"Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells","volume":"77","author":"Cowley","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201320_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/565839","article-title":"The p85 Regulatory Subunit of PI3K Mediates cAMP-PKA and Insulin Biological Effects on MCF-7 Cell Growth and Motility","volume":"2014","author":"Di Zazzo","year":"2014","journal-title":"ScientificWorldJournal."}],"updated-by":[{"DOI":"10.1016\/j.omton.2026.201350","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,12,17]],"date-time":"2026-12-17T00:00:00Z","timestamp":1797465600000}}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:33:07Z","timestamp":1790253187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926001967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2950329926001967"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201320","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additive effect of Ruta graveolens bioactive phytoconstituents and cisplatin through PKC\/MEK\/ERK pathway in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201320"}}